Investigational Site

Chicago, Illinois 60657

0 studies enrolling now · 18 studies all time

What they study most

Age-related Macular Degeneration, Atopic Dermatitis, Augmented Renal Clearance (ARC), Bipolar Disorder, Dermatitis, Atopic, End Stage Renal Disease (ESRD), Infections, Low Back Pain, Methicillin-resistant Staphylococcus Aureus (MRSA) Bacteremia, Migraine Prophylaxis, Moderate or Severe Submental Fullness, Pain

Studies at this site

• A Study Evaluating APG777 in Atopic Dermatitis — Running, not enrolling
• Performance Evaluation of the AMIA APD Solution Generation System in Patients End Stage Renal Disease (ESRD) — Stopped early
• Non-Invasive Cooling of Fat Cells — Completed
• A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD) — Completed
• Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis — Completed
• Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis — Completed
• Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD — Status unconfirmed
• Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance — Completed
• Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder — Completed
• Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus — Completed
• Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area — Completed
• Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area — Completed
• Efficacy and Safety Study of E2007 in Migraine Prophylaxis — Completed
• A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain — Completed
• A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis — Completed
• Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia — Completed
• Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN) — Completed